Therapy of diseases caused by Chlamydia organisms.
D002689:Chlamydia / Q000302:isolation & purification; D002690:Chlamydia Infections / Q000175:diagnosis / Q000628:therapy*; D003168:Complement Fixation Tests; D003231:Conjunctivitis / Q000628:therapy; D003235:Conjunctivitis, Inclusion / Q000175:diagnosis / Q000628:therapy; D004917:Erythromycin / Q000627:therapeutic use; D005128:Eye Diseases / Q000628:therapy*; D005455:Fluorescent Antibody Technique; D006801:Humans; D013409:Sulfacetamide / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014141:Trachoma / Q000175:diagnosis / Q000628:therapy*
D013449:Sulfonamides; D013409:Sulfacetamide; D004917:Erythromycin; D013752:Tetracycline